Hemostasis & Thrombosis Research Society (HTRS) Scientific Symposium 2017
Event Date: April 6 - 8, 2017
Event Location: DoubleTree Resort by Hilton - Paradise Valley, 5401 N. Scottsdale Rd, Scottsdale, AZ 85250-7090
The tenth professional HTRS meeting offers a dynamic range of topics in hemostasis and thrombosis in both pediatrics and adult medicine to best fit the needs and requests of diverse audience of residents and fellows; junior faculty members and well established coagulationists; hematologists, general internists, cardiologists, and pulmonologists; hemophilia and thrombosis nurses, representatives from industry, and all professionals caring for patients with disorders of bleeding and thrombosis.
HTRS is a North American professional medical society with over 500 members from the U.S. and Canada. They are a nonprofit, 501(c)(3) organization incorporated in the State of Wisconsin in 1994. Their members are physicians, researchers, nurses, nurse practitioners, pharmacists, representatives from industry, and any health care professionals involved in caring for pediatric and adult patients with bleeding and/or thrombotic disorders.
- Grants and awards for fellows, junior faculty/junior attending, and experienced academic researchers in benign hematology.
- Continuing education for physicians, nurses, and pharmacists at biennial HTRS Scientific Symposia.
- Career development networks for fellows and junior faculty/junior attending.
- Trainee Workshops prior to national meetings to foster the next generation of academic hematologists.
HTRS 2017 Educational Objective
- Describe new diagnostic techniques in the diagnosis and management of thrombotic and bleeding disorders
- Describe new therapies for the treatment of thrombotic and bleeding disorders
- Identify knowledge gaps in thrombotic and bleeding disorders that can be incorporated into future research
HTRS 2017 Target Audience
Physicians, nurses, pharmacists, and other allied health professionals involved in the management, treatment or referral of pediatric and/or adult patients with bleeding and thrombotic disorders.